HIPK2 Antibody, HRP conjugated

1. The downregulation of miR-197 suppresses the EMT and migration ability. HIPK2 is a direct functional target of miR-197 in LAD metastasis. In summary, miR-197 controls EMT and metastasis by directly silencing HIPK2. PMID:29666324
2. HIPK2 polymorphisms rs2058265, rs6464214, and rs7456421 may have a role in kidney stone disease in Chinese males PMID:29428801
3. HIPK2 overexpression may be a potential prognostic marker for predicting prognoses and a high risk of recurrence, particularly in patients with HPV-positive Tonsillar squamous cell carcinomas. PMID:28607924
4. Furthermore, our results suggest that modulation of either HIPK2 levels or activity could be exploited to impair NRF2-mediated signalling in cancer cells, and thus sensitise them to chemotherapeutic drugs. PMID:28692050
5. PARP1 can modulate the tumor-suppressing function of HIPK2 by regulating the protein stability of HIPK2. PMID:27787517
6. Data show that HIPK2-T566 phosphorylation contributes to UV-induced HIPK2 activity but it is dispensable for doxorubicin response. PMID:28060750
7. In this study, we report that the kinase HIPK2 is responsible for facilitating the Fbw7-dependent proteasomal degradation of Notch1 by phosphorylating its intracellular domain (Notch1-IC) within the Cdc4 phosphodegron motif. PMID:27335110
8. These results suggest that the HIPK2-phospho-Ser271 CREB axis is a new arsenic-responsive CREB activation mechanism in parallel with the PKA-phospho-Ser133 CREB axis. PMID:27884605
9. Results demonstrated that HIPK2 may function as a novel regulator to modulate hepatic stellate cells activation, potentially by inhibiting the TGF-beta1/Smad3 signaling pathway. PMID:27890429
10. Data show strong reduction of cell viability was induced in vitro and in vivo by the homeodomain interacting protein kinase 2 exon 8 spliced isoform (Hipk2-Deltae8)-specific siRNA, supporting a potential therapeutic application. PMID:26625198
11. Results indicate that Hipk2 exerts a relevant role in the survival of cerebellar Purkinje cells and that Hipk2 genetic ablation generates cerebellar dysfunction compatible with an ataxic-like phenotype. PMID:26633710
12. The findings highlight a complex regulation of CREB-binding protein activity by HIPK2, which might be relevant for the control of specific sets of target genes involved in cellular proliferation, differentiation and apoptosis. PMID:26247811
13. MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response. PMID:25961923
14. Results indicate that HIPK2 acts as a caretaker gene, whose inactivation increases tumorigenicity and causes chromosomal instability by cytokinesis failure. PMID:25868975
15. HIPK2 expression tends to be decreased along tumor progression and may be involved with the invasive potential, suggesting a possible tumor suppressor role for HIPK2. PMID:25711204
16. c-Abl was required for endogenous HIPK2 accumulation and phosphorylation of p53 at Ser46 in response to DNA damage by gamma- and UV radiation. PMID:25944899
17. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway. PMID:26102034
18. HIPK2/HP1gamma pathway may uncover a new functional aspect of HIPK2 as a tumor suppressor. PMID:25151962
19. the role and mechanism of miR141 in regulating renal fibrosis via the TGFbeta1/miR-141/HIPK2/EMT axis PMID:25421593
20. Results show that downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1. PMID:24846322
21. Ras induces the formation of a complex between NORE1A and the kinase HIPK2, enhancing HIPK2 association with p53. PMID:25778922
22. Hipk2 knockdown resulted in decreased E-cadherin expression and increased N-cadherin and fibronectin expression, and induced Wnt signaling activation and beta-catenin nuclear localization, indicating that epithelial-mesenchymal transition was induced. PMID:24824041
23. Homeodomain-interacting protein kinase 2, a novel autoimmune regulator interaction partner, modulates promiscuous gene expression in medullary thymic epithelial cells PMID:25552543
24. XAF1 stimulates HIPK2-mediated Ser-46 phosphorylation of p53 and XAF1 also steps up the termination of p53-mediated cell-cycle arrest by activating ZNF313. PMID:25313037
25. These results provide evidence that HIPK2 and Pin1 work together to promote cortical neurogenesis, at least in part, by suppressing Gro/TLE1:Hes1-mediated inhibition of neuronal differentiation. PMID:24270405
26. In response to severe DNA damage, p53 phosphorylation at Ser46 is promoted by the accumulation of HIPK2 due to downregulation of nuclear Mdm2 in the later phase of the response. PMID:24829283
27. our results suggest that Src kinase suppresses the apoptotic p53 pathway by phosphorylating HIPK2 and relocalizing the kinase to the cytoplasm. PMID:24196445
28. activation of the IL-4/STAT6 signaling pathway has a crucial role in aberrant glycosylation of IgA1 secretion, which is mediated by HIPK2 PMID:24107646
29. PKA-mediated phosphorylation of PML-RARalpha blocked its ability to inhibit PML oligomerization and destabilize HIPK2. PMID:23722549
30. HIPK2 autointeracts and site-specifically autophosphorylates upon DNA damage at Thr880/Ser882. PMID:24145406
31. In response to ionizing radiation, HIPK2 phosphorylation promotes inhibition of WIP1 phosphorylation through dissociation of WIP1 from HIPK2, followed by stabilization of WIP1 for termination of the ATM-mediated double-strand break signaling cascade. PMID:23871434
32. HIPK2 silencing may contribute to induce resistance to cell death in glucose restriction condition. PMID:23703384
33. HIPK1 and HIPK2, are transcriptional corepressors that regulate TGF-beta-dependent angiogenesis during embryonic development. PMID:23565059
34. On the basis of transmission disequilibrium test results, the influence of 2 single nucleotide polymorphisms of HIPK2 gene on prevalence of chronic kidney disease was not identified. PMID:23540226
35. HIPK2 knockdown in colon cancer cells resulted in cyclooxygenase-2 upregulation and COX-2-derived PGE(2) generation. PMID:23144866
36. HIPK2 dysfunction may play a role in fibroblasts behavior and in idiopathic pulmonary fibrosis pathogenesis. PMID:22689412
37. Data indicate a critical kinase HIPK2 function in cytokinesis and in the prevention of tetraploidization. PMID:22658722
38. Data show that vimentin is a novel target for HIPK2 repressor function and that HIPK2-mediated vimentin downregulation can contribute to inhibition of breast cancer cells invasion. PMID:22236966
39. identify ROS-induced acetylation of the proapoptotic kinase HIPK2 as a molecular mechanism that controls the threshold discerning sensitivity from resistance toward ROS-mediated cell death PMID:22503103
40. HIPK2 expression is higher in cervical cancer tissues and has a positive correlation with cervical cancer. HIPK2 may be important in the development of cervical cancer. PMID:22395153
41. This study identified homeo-domain interacting protein kinase 2 (HIPK2) as a key regulator of kidney fibrosis. PMID:22406746
42. cutaneous HPV23 E6 prevents HIPK2-mediated p53 Ser 46 phosphorylation PMID:22110707
43. show that HIPK2 depletion interferes with DeltaNp63alpha degradation, and expression of a HIPK2-resistant DeltaNp63alpha-Delta390 mutant induces chemoresistance PMID:21602882
44. our results point to a prominent and p53-independent role of HIPK2 in colon cancer survival. PMID:21514416
45. Thus, these results suggest that the mutations of the HIPK2 gene maybe a rare event in the development of KA and SCC of the skin in Korean population. PMID:21569099
46. Findings suggest an unforeseen role for Zyxin in DNA damage-induced cell fate control through modulating the HIPK2-p53 signaling axis. PMID:21248071
47. HIPK2 up-regulates transcription by phosphorylating TCF3, a transcriptional repressor, but inhibits transcription by phosphorylating LEF1, a transcriptional activator. PMID:21285352
48. These findings identify a novel circuitry between HIF-1alpha and p53, and provide a paradigm for HIPK2 dictating cell response to antitumor therapies. PMID:21248371
49. beta-amyloid 1-40 induces HIPK2 degradation and alters HIPK2 binding activity to DNA, in turn regulating the p53 conformational state and vulnerability to a noxious stimulus. PMID:20418953
50. These results suggest that SUMO interaction motif-mediated HIPK2 targeting to PML-NBs is crucial for HIPK2-mediated p53 activation and induction of apoptosis. PMID:21192925

Show More

Hide All

HGNC: 14402

UNIGENE: Hs.731417

KEGG: hsa:28996

STRING: 9606.ENSP00000385571

OMIM: 606868